Cargando…
Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach
A major challenge in translating genomic variants of Tuberculosis (TB) into clinical implementation is to integrate the disease-associated variants and facilitate drug discovery through the concept of genomic-driven drug repurposing. Here, we utilized two established genomic databases, namely a Geno...
Autores principales: | Irham, Lalu Muhammad, Adikusuma, Wirawan, Perwitasari, Dyah Aryani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449755/ https://www.ncbi.nlm.nih.gov/pubmed/36090591 http://dx.doi.org/10.1016/j.bbrep.2022.101334 |
Ejemplares similares
-
Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis
por: Afief, Arief Rahman, et al.
Publicado: (2022) -
The use of genomic variants to drive drug repurposing for chronic hepatitis B
por: Irham, Lalu Muhammad, et al.
Publicado: (2022) -
Identification of Hub Genes and Potential Biomarkers for Childhood Asthma by Utilizing an Established Bioinformatic Analysis Approach
por: Santri, Ichtiarini Nurullita, et al.
Publicado: (2022) -
Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information
por: Adikusuma, Wirawan, et al.
Publicado: (2021) -
Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis
por: Adikusuma, Wirawan, et al.
Publicado: (2022)